These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 23052939)

  • 1. Effects of anti-resorptive agents on trabecular bone score (TBS) in older women.
    Krieg MA; Aubry-Rozier B; Hans D; Leslie WD;
    Osteoporos Int; 2013 Mar; 24(3):1073-8. PubMed ID: 23052939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of teriparatide and ibandronate on spine bone mineral density (BMD) and microarchitecture (TBS) in postmenopausal women with osteoporosis: a 2-year open-label study.
    Senn C; Günther B; Popp AW; Perrelet R; Hans D; Lippuner K
    Osteoporos Int; 2014 Jul; 25(7):1945-51. PubMed ID: 24760244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of denosumab on trabecular bone score in postmenopausal women with osteoporosis.
    McClung MR; Lippuner K; Brandi ML; Zanchetta JR; Bone HG; Chapurlat R; Hans D; Wang A; Zapalowski C; Libanati C
    Osteoporos Int; 2017 Oct; 28(10):2967-2973. PubMed ID: 28748386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal changes in bone mineral density and trabecular bone score following yearly zoledronic acid infusion in postmenopausal osteoporosis-a retrospective-prospective study from southern India.
    Sooragonda B; Cherian KE; Jebasingh FK; Dasgupta R; Asha HS; Kapoor N; Thomas N; Paul TV
    Arch Osteoporos; 2019 Jul; 14(1):79. PubMed ID: 31321603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of zoledronic acid versus placebo on bone mineral density and bone texture analysis assessed by the trabecular bone score in premenopausal women with breast cancer treatment-induced bone loss: results of the ProBONE II substudy.
    Kalder M; Kyvernitakis I; Albert US; Baier-Ebert M; Hadji P
    Osteoporos Int; 2015 Jan; 26(1):353-60. PubMed ID: 25381047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which is the preferred site for bone mineral density monitoring as an indicator of treatment-related anti-fracture effect in routine clinical practice? A registry-based cohort study.
    Leslie WD; Martineau P; Bryanton M; Lix LM
    Osteoporos Int; 2019 Jul; 30(7):1445-1453. PubMed ID: 31016351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contributions of Clinical and Technical Factors to Longitudinal Change in Trabecular Bone Score and Bone Density: A Registry-Based Individual-Level Analysis.
    Leslie WD; Goel H; Binkley N; McCloskey EV; Hans D
    J Bone Miner Res; 2023 Apr; 38(4):512-521. PubMed ID: 36655775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fracture Prediction from Trabecular Bone Score is Unaffected by Anti-Resorptive Treatment: A Registry-Based Cohort Study.
    Leslie WD; Hans D; Silva BC
    J Clin Densitom; 2023; 26(1):10-15. PubMed ID: 36696814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of glucocorticoid therapy on trabecular bone score in older women.
    Paggiosi MA; Peel NF; Eastell R
    Osteoporos Int; 2015 Jun; 26(6):1773-80. PubMed ID: 25743176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is bone microarchitecture status of the lumbar spine assessed by TBS related to femoral neck fracture? A Spanish case-control study.
    Del Rio LM; Winzenrieth R; Cormier C; Di Gregorio S
    Osteoporos Int; 2013 Mar; 24(3):991-8. PubMed ID: 22581295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study.
    Hans D; Goertzen AL; Krieg MA; Leslie WD
    J Bone Miner Res; 2011 Nov; 26(11):2762-9. PubMed ID: 21887701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing Change in Spine Bone Density from Different Numbers and Combinations of Lumbar Vertebrae: The Manitoba BMD Registry.
    Szalat A; Rosen H; Leslie WD
    J Clin Densitom; 2024; 27(3):101493. PubMed ID: 38643731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Change in Trabecular Bone Score (TBS) With Antiresorptive Therapy Does Not Predict Fracture in Women: The Manitoba BMD Cohort.
    Leslie WD; Majumdar SR; Morin SN; Hans D; Lix LM
    J Bone Miner Res; 2017 Mar; 32(3):618-623. PubMed ID: 27933656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lumbar spine texture enhances 10-year fracture probability assessment.
    Leslie WD; Johansson H; Kanis JA; Lamy O; Oden A; McCloskey EV; Hans D
    Osteoporos Int; 2014 Sep; 25(9):2271-7. PubMed ID: 24951032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical factors associated with trabecular bone score.
    Leslie WD; Krieg MA; Hans D;
    J Clin Densitom; 2013; 16(3):374-379. PubMed ID: 23452869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of zoledronate versus placebo on spine bone mineral density and microarchitecture assessed by the trabecular bone score in postmenopausal women with osteoporosis: a three-year study.
    Popp AW; Guler S; Lamy O; Senn C; Buffat H; Perrelet R; Hans D; Lippuner K
    J Bone Miner Res; 2013 Mar; 28(3):449-54. PubMed ID: 23018784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abaloparatide-SC improves trabecular microarchitecture as assessed by trabecular bone score (TBS): a 24-week randomized clinical trial.
    Bilezikian JP; Hattersley G; Fitzpatrick LA; Harris AG; Shevroja E; Banks K; Leder BZ; Zanchetta JR; Hans D
    Osteoporos Int; 2018 Feb; 29(2):323-328. PubMed ID: 29167971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of once-yearly zoledronic acid on the spine and hip as measured by quantitative computed tomography: results of the HORIZON Pivotal Fracture Trial.
    Eastell R; Lang T; Boonen S; Cummings S; Delmas PD; Cauley JA; Horowitz Z; Kerzberg E; Bianchi G; Kendler D; Leung P; Man Z; Mesenbrink P; Eriksen EF; Black DM;
    Osteoporos Int; 2010 Jul; 21(7):1277-85. PubMed ID: 19802508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the effects of long-term osteoporosis treatment by using conventional spine radiographs: results from a pilot study in a sub-cohort of a large randomized controlled trial.
    Dimai HP; Ljuhar R; Ljuhar D; Norman B; Nehrer S; Kurth A; Fahrleitner-Pammer A
    Skeletal Radiol; 2019 Jul; 48(7):1023-1032. PubMed ID: 30506302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effect of aromatase inhibitors on bone microarchitecture and macroarchitecture in non-osteoporotic postmenopausal women with breast cancer.
    Hong AR; Kim JH; Lee KH; Kim TY; Im SA; Kim TY; Moon HG; Han WS; Noh DY; Kim SW; Shin CS
    Osteoporos Int; 2017 Apr; 28(4):1413-1422. PubMed ID: 28083668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.